- Home
- CGC vs ANGO Comparison
CGC vs ANGO Comparison
Compare CGC & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CGC | ANGO |
|---|---|---|
| Founded | N/A | 1988 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 404.3M | 420.2M |
| IPO Year | 2023 | 2004 |
Fundamental Metrics
Financial Performance| Metric | CGC | ANGO |
|---|---|---|
| Price | $1.09 | $10.84 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | ★ 13.1M | 327.8K |
| Earning Date | 05-29-2026 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 36.75 | ★ 81.92 |
| EPS | ★ N/A | N/A |
| Revenue | $12,759,000.00 | ★ $291,010,000.00 |
| Revenue This Year | $8.27 | $9.51 |
| Revenue Next Year | $15.68 | $4.96 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $0.84 | $8.36 |
| 52 Week High | $2.38 | $13.99 |
Technical Indicators
Market Signals| Indicator | CGC | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 47.20 | 48.96 |
| Support Level | $1.01 | $10.40 |
| Resistance Level | $1.10 | $11.13 |
| Average True Range (ATR) | 0.05 | 0.32 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 6.73 | 36.36 |
Price Performance
Historical ComparisonAbout CGC Canopy Growth Corporation
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.